Drug Dosage Form Design I Summary

Lecture Summary on Pharmaceutical Dosage Forms
  • Learning Objectives

    • Reasons for incorporating drugs into dosage forms: This involves understanding why active pharmaceutical ingredients (APIs) are not administered in their raw form, but rather integrated into sophisticated delivery systems to ensure efficacy, safety, and patient compliance.

    • Comparison of advantages/disadvantages of different dosage forms: Analyzing various forms (e.g., solid, liquid, semi-solid, gaseous) to determine their suitability for specific therapeutic goals, routes of administration, and patient populations.

    • Overview of preformulation studies: Understanding the initial phase of drug development where the physical and chemical properties of a drug substance are characterized to guide dosage form design.

    • Categorization of pharmaceutical ingredients and excipients: Identifying the roles and types of all components in a drug product, beyond just the active drug itself.

  • Terminologies

    • Formulations: The physical form in which a drug is manufactured for administration, containing the active drug and excipients.

    • Drug Delivery Systems: Technologies designed to enhance the delivery of a drug to its target in the body, often controlling the rate, time, and site of release.

    • Dosage Forms: The physical manifestation of the drug product, e.g., tablet, capsule, injection, syrup.

    • Pharmaceutical Products: The final commercialized product containing the drug substance and excipients, ready for patient use.

    • Excipients: Inactive ingredients added to a drug formulation for specific purposes, such as stability, appearance, or processing.

  • Need for Dosage Forms

    • Drugs are administered as part of a formulation rather than alone for effectiveness, patient compliance, and controlled delivery.

    • Benefits include protecting the drug from degradation, masking unpleasant tastes/odors, facilitating accurate dosing, promoting absorption, and enabling targeted delivery.

  • Design Considerations

    • A good dosage form optimizes drug therapy by combining active drug (API) with excipients to achieve desired therapeutic outcomes.

    • The design aims to maximize bioavailability, minimize side effects, ensure stability over time, and provide ease of administration.

    • Drug product consists of active ingredients (API) and carefully selected excipients that fulfill specific functional roles.

  • Categories of Excipients

    • Functional roles include bulking agents (e.g., lactose, microcrystalline cellulose), fillers, binders (e.g., povidone, starch), disintegrants (e.g., croscarmellose sodium), lubricants (e.g., magnesium stearate), stabilizers (antioxidants, preservatives), colorants, and flavorants.

    • Excipients are essential for drug solubility, stability (preventing chemical or physical degradation), manufacturability, and absorption from the site of administration.

  • Biopharmaceutical Considerations

    • Factors influencing dosage form design:

      • Therapeutic indication: The specific condition being treated dictates the required drug concentration, duration of action, and site of action.

      • Patient age: Considerations for pediatric (e.g., liquid formulations) and geriatric (e.g., smaller tablets, easy-to-swallow forms) populations are crucial.

      • Bioavailability: The fraction of an administered dose of unchanged drug that reaches the systemic circulation; dosage forms are designed to optimize this.

      • Drug stability: Maintaining the chemical integrity and potency of the drug throughout its shelf life under various storage conditions.

    • Importance of preformulation studies for design decisions: These studies provide critical data on the physical and chemical properties of the API (e.g., solubility, pKa, stability), guiding the selection of excipients and the overall formulation strategy.

  • Physico-Chemical Properties of Drugs

    • Crucial properties include:

      • Molecular structure: Influences intrinsic solubility, lipophilicity, and potential for intermolecular interactions.

      • Melting point: Indicates thermal stability and can affect processing methods (e.g., granulation, compression).

      • Particle size: Affects dissolution rate, which directly impacts solubility and absorption rates, especially for poorly soluble drugs. Smaller particles generally lead to faster dissolution.

      • Hygroscopicity: The tendency of a drug to absorb moisture from the atmosphere, which can compromise stability and physical properties.

      • Crystallinity/Amorphism: The internal structure of the drug; crystalline forms are typically more stable but less soluble than amorphous forms.

  • Polymorphism

    • Polymorphism refers to a drug existing in multiple crystal forms, or polymorphs, which have different internal arrangements of molecules. These polymorphs can impact stability, solubility, and absorption rates.

    • For instance, one polymorph might be more soluble than another, leading to differences in dissolution rate and potentially affecting bioavailability.

    • Monitoring is essential due to implications on efficacy and safety, as a change in polymorph during manufacturing or storage can alter the drug's performance.

  • Solubility Considerations

    • Essential for drug absorption from the gastrointestinal tract or other administration sites into the bloodstream.

    • Drug solubility is significantly influenced by its chemical structure (e.g., presence of polar/non-polar groups) and the pH levels of the surrounding environment.

    • For ionizable drugs, the Henderson-Hasselbalch equation (Acidic: pH=pKa+log([A][HA])pH = pKa + \log(\frac{[A^-]}{[HA]}); Basic: pH=pKa+log([B][BH+])pH = pKa + \log(\frac{[B]}{[BH^+]})) helps predict ionization state and solubility at different pHs.

    • Use of buffers (e.g., phosphate, citrate buffers) in formulations to maintain optimal pH for stability and solubility, thus preventing degradation or precipitation of the drug.

  • Partition Coefficient

    • Reflects the balance between a drug's hydrophilicity (water-loving) and lipophilicity (fat-loving), typically expressed as P = [Coil]/[Cwater], where [Coil] is the concentration in an oil phase (e.g., octanol) and [Cwater] is the concentration in an aqueous phase.

    • The logarithm of the partition coefficient (log P) is often used. A higher log P value indicates greater lipophilicity.

    • This coefficient indicates the drug's ability to cross biological membranes (which are lipidic), making it crucial for predicting absorption, distribution, metabolism, and excretion (ADME) properties.